Found: 36
Select item for more details and to access through your institution.
Editorial: Novel roles for tumorassociated neutrophils.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1004772
- By:
- Publication type:
- Article
Editorial: Glycans: Masters of immunity, from cancers to inflammatory disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.1002679
- By:
- Publication type:
- Article
Glioblastoma in the oldest old: Clinical characteristics, therapy, and outcome in patients aged 80 years and older.
- Published in:
- Neuro-Oncology Practice, 2024, v. 11, n. 2, p. 132, doi. 10.1093/nop/npad070
- By:
- Publication type:
- Article
Immune tumor board: integral part in the multidisciplinary management of cancer patients treated with cancer immunotherapy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeting sialic acid–Siglec interactions to reverse immune suppression in cancer.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 640, doi. 10.1093/glycob/cwx108
- By:
- Publication type:
- Article
Cancer Immunotherapy.
- Published in:
- Glycobiology, 2018, v. 28, n. 9, p. 638, doi. 10.1093/glycob/cwy069
- By:
- Publication type:
- Article
Sialic acids in cancer biology and immunity.
- Published in:
- Glycobiology, 2016, v. 26, n. 2, p. 111, doi. 10.1093/glycob/cwv097
- By:
- Publication type:
- Article
Siglec receptors impact mammalian lifespan by modulating oxidative stress.
- Published in:
- eLife, 2015, p. 1, doi. 10.7554/eLife.06184.001
- By:
- Publication type:
- Article
Involvement of a non-human sialic acid in human cancer.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00033
- By:
- Publication type:
- Article
Tetra‐ and Hexavalent Siglec‐8 Ligands Modulate Immune Cell Activation.
- Published in:
- Angewandte Chemie International Edition, 2023, v. 62, n. 52, p. 1, doi. 10.1002/anie.202314280
- By:
- Publication type:
- Article
Loss of Lymphotoxin Alpha-Expressing Memory B Cells Correlates with Metastasis of Human Primary Melanoma.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 7, p. 1238, doi. 10.3390/diagnostics11071238
- By:
- Publication type:
- Article
Zelluläre Immuntherapien von Malignomen - Wie wirken sie und welche Nebenwirkungen sind zu erwarten.
- Published in:
- Therapeutische Umschau, 2023, v. 80, n. 8, p. 348
- By:
- Publication type:
- Article
Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non‐small cell lung cancer.
- Published in:
- Journal of Pathology, 2020, v. 250, n. 1, p. 19, doi. 10.1002/path.5344
- By:
- Publication type:
- Article
speedingCARs: accelerating the engineering of CAR T cells by signaling domain shuffling and single-cell sequencing.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-34141-8
- By:
- Publication type:
- Article
Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses.
- Published in:
- Cellular & Molecular Life Sciences, 2020, v. 77, n. 4, p. 593, doi. 10.1007/s00018-019-03288-x
- By:
- Publication type:
- Article
PD-1+ natural killer cells in human non-small cell lung cancer can be activated by PD-1/PD-L1 blockade.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 8, p. 1505, doi. 10.1007/s00262-020-02558-z
- By:
- Publication type:
- Article
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 5, p. 815, doi. 10.1007/s00262-018-2136-x
- By:
- Publication type:
- Article
Larotrectinib Response in NTRK3 Fusion-Driven Diffuse High-Grade Glioma.
- Published in:
- Pharmacology, 2022, v. 107, n. 7/8, p. 433, doi. 10.1159/000524399
- By:
- Publication type:
- Article
Mechanisms of Immune-Related Complications in Cancer Patients Treated with Immune Checkpoint Inhibitors.
- Published in:
- Pharmacology, 2021, v. 106, n. 3-4, p. 123, doi. 10.1159/000509081
- By:
- Publication type:
- Article
Case report of elevation of high-sensitivity cardiac troponin T in the absence of cardiac involvement in immune checkpoint inhibitor-associated myositis.
- Published in:
- European Heart Journal Case Reports, 2022, v. 6, n. 9, p. 1, doi. 10.1093/ehjcr/ytac353
- By:
- Publication type:
- Article
Detection of N-glycolylneuraminic acid-containing glycolipids in human skin.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1291292
- By:
- Publication type:
- Article
Pembrolizumab-induced optic neuropathy - a case report.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1171981
- By:
- Publication type:
- Article
Changes of peripheral T cell subsets in melanoma patients with immune-related adverse events.
- Published in:
- Frontiers in Immunology, 2023, v. 14, p. 1, doi. 10.3389/fimmu.2023.1125111
- By:
- Publication type:
- Article
B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-12160-2
- By:
- Publication type:
- Article
Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 705, p. 1, doi. 10.1126/scitranslmed.adf5302
- By:
- Publication type:
- Article
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 670, p. 1, doi. 10.1126/scitranslmed.abo3605
- By:
- Publication type:
- Article
NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 653, p. 1, doi. 10.1126/scitranslmed.abm9043
- By:
- Publication type:
- Article
Effects of COVID-19 Lockdown on Melanoma Diagnosis in Switzerland: Increased Tumor Thickness in Elderly Females and Shift towards Stage IV Melanoma during Lockdown.
- Published in:
- Cancers, 2022, v. 14, n. 10, p. 2360, doi. 10.3390/cancers14102360
- By:
- Publication type:
- Article
Cross-Reactivity and Functionality of Approved Human Immune Checkpoint Blockers in Dogs.
- Published in:
- Cancers, 2021, v. 13, n. 4, p. 785, doi. 10.3390/cancers13040785
- By:
- Publication type:
- Article
Tetra‐ and Hexavalent Siglec‐8 Ligands Modulate Immune Cell Activation.
- Published in:
- Angewandte Chemie, 2023, v. 135, n. 52, p. 1, doi. 10.1002/ange.202314280
- By:
- Publication type:
- Article
Design of a mucin-selective protease for targeted degradation of cancer-associated mucins.
- Published in:
- Nature Biotechnology, 2024, v. 42, n. 4, p. 597, doi. 10.1038/s41587-023-01840-6
- By:
- Publication type:
- Article
A Standardized Analysis of Tertiary Lymphoid Structures in Human Melanoma: Disease Progression- and Tumor Site-Associated Changes With Germinal Center Alteration.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.675146
- By:
- Publication type:
- Article
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Response to Comment on Trinh et al. Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab. Diabetes Care 2019;42:e153-e154.
- Published in:
- 2020
- By:
- Publication type:
- letter
Successful Treatment of Immune Checkpoint Inhibitor-Induced Diabetes With Infliximab.
- Published in:
- 2019
- By:
- Publication type:
- letter
Tools to study and target the Siglec–sialic acid axis in cancer.
- Published in:
- FEBS Journal, 2021, v. 288, n. 21, p. 6206, doi. 10.1111/febs.15647
- By:
- Publication type:
- Article